BAUSCH + LOMB CORP (BLCO) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:BLCO • CA0717051076

17 USD
+0.59 (+3.6%)
At close: Feb 6, 2026
17 USD
0 (0%)
After Hours: 2/6/2026, 8:19:46 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

BLCO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. While BLCO is still in line with the averages on profitability rating, there are concerns on its financial health. BLCO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year BLCO was profitable.
  • In the past year BLCO had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: BLCO reported negative net income in multiple years.
  • BLCO had a positive operating cash flow in 4 of the past 5 years.
BLCO Yearly Net Income VS EBIT VS OCF VS FCFBLCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

  • BLCO's Return On Assets of -2.21% is fine compared to the rest of the industry. BLCO outperforms 70.43% of its industry peers.
  • BLCO has a better Return On Equity (-4.74%) than 70.97% of its industry peers.
  • BLCO has a better Return On Invested Capital (0.77%) than 66.67% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BLCO is significantly below the industry average of 8.80%.
Industry RankSector Rank
ROA -2.21%
ROE -4.74%
ROIC 0.77%
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.59%
ROIC(5y)1.92%
BLCO Yearly ROA, ROE, ROICBLCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4

1.3 Margins

  • The Operating Margin of BLCO (2.33%) is better than 67.74% of its industry peers.
  • BLCO's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 59.45%, BLCO is in the better half of the industry, outperforming 60.22% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BLCO has remained more or less at the same level.
Industry RankSector Rank
OM 2.33%
PM (TTM) N/A
GM 59.45%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
BLCO Yearly Profit, Operating, Gross MarginsBLCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BLCO is destroying value.
  • Compared to 1 year ago, BLCO has more shares outstanding
  • BLCO has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BLCO has a worse debt to assets ratio.
BLCO Yearly Shares OutstandingBLCO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
BLCO Yearly Total Debt VS Total AssetsBLCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • Based on the Altman-Z score of 0.87, we must say that BLCO is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of BLCO (0.87) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.77 indicates that BLCO is somewhat dependend on debt financing.
  • The Debt to Equity ratio of BLCO (0.77) is worse than 69.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Altman-Z 0.87
ROIC/WACC0.08
WACC10.03%
BLCO Yearly LT Debt VS Equity VS FCFBLCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

  • BLCO has a Current Ratio of 1.51. This is a normal value and indicates that BLCO is financially healthy and should not expect problems in meeting its short term obligations.
  • BLCO's Current ratio of 1.51 is on the low side compared to the rest of the industry. BLCO is outperformed by 73.12% of its industry peers.
  • BLCO has a Quick Ratio of 1.51. This is a bad value and indicates that BLCO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of BLCO (0.98) is worse than 75.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 0.98
BLCO Yearly Current Assets VS Current LiabilitesBLCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • BLCO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.51%.
  • BLCO shows a small growth in Revenue. In the last year, the Revenue has grown by 6.23%.
  • BLCO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.87% yearly.
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%

3.2 Future

  • BLCO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.96% yearly.
  • The Revenue is expected to grow by 5.49% on average over the next years.
EPS Next Y-10.8%
EPS Next 2Y13.94%
EPS Next 3Y20.44%
EPS Next 5Y19.96%
Revenue Next Year6.46%
Revenue Next 2Y6.14%
Revenue Next 3Y5.92%
Revenue Next 5Y5.49%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BLCO Yearly Revenue VS EstimatesBLCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
BLCO Yearly EPS VS EstimatesBLCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 39.53, the valuation of BLCO can be described as expensive.
  • BLCO's Price/Earnings ratio is a bit cheaper when compared to the industry. BLCO is cheaper than 70.97% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.93, BLCO is valued a bit more expensive.
  • Based on the Price/Forward Earnings ratio of 21.12, the valuation of BLCO can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, BLCO is valued cheaply inside the industry as 80.11% of the companies are valued more expensively.
  • BLCO's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.77.
Industry RankSector Rank
PE 39.53
Fwd PE 21.12
BLCO Price Earnings VS Forward Price EarningsBLCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BLCO is valued a bit cheaper than 75.81% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.6
BLCO Per share dataBLCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as BLCO's earnings are expected to grow with 20.44% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.94%
EPS Next 3Y20.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for BLCO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BAUSCH + LOMB CORP

NYSE:BLCO (2/6/2026, 8:19:46 PM)

After market: 17 0 (0%)

17

+0.59 (+3.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29
Earnings (Next)02-18
Inst Owners11.05%
Inst Owner Change-0.67%
Ins Owners0.45%
Ins Owner Change0.1%
Market Cap6.02B
Revenue(TTM)4.98B
Net Income(TTM)-305.00M
Analysts72.63
Price Target17.68 (4%)
Short Float %9.56%
Short Ratio11.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.13%
Min EPS beat(2)1.79%
Max EPS beat(2)8.47%
EPS beat(4)3
Avg EPS beat(4)-86.5%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)6
Avg EPS beat(8)-37.66%
EPS beat(12)9
Avg EPS beat(12)-24.06%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.15%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.39%
Revenue beat(4)0
Avg Revenue beat(4)-1.38%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.16%
Revenue beat(8)3
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)0.82%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.96%
PT rev (3m)14.6%
EPS NQ rev (1m)-3.3%
EPS NQ rev (3m)-5.77%
EPS NY rev (1m)0.21%
EPS NY rev (3m)0.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 39.53
Fwd PE 21.12
P/S 1.21
P/FCF N/A
P/OCF 35.63
P/B 0.94
P/tB N/A
EV/EBITDA 19.6
EPS(TTM)0.43
EY2.53%
EPS(NY)0.8
Fwd EY4.73%
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)0.48
OCFY2.81%
SpS14.05
BVpS18.15
TBVpS-4.39
PEG (NY)N/A
PEG (5Y)N/A
Graham Number13.25
Profitability
Industry RankSector Rank
ROA -2.21%
ROE -4.74%
ROCE 0.97%
ROIC 0.77%
ROICexc 0.79%
ROICexgc 2.52%
OM 2.33%
PM (TTM) N/A
GM 59.45%
FCFM N/A
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.59%
ROIC(5y)1.92%
ROICexc(3y)1.64%
ROICexc(5y)1.97%
ROICexgc(3y)5.47%
ROICexgc(5y)6.76%
ROCE(3y)2.02%
ROCE(5y)2.43%
ROICexgc growth 3Y-21.86%
ROICexgc growth 5Y-17.06%
ROICexc growth 3Y-20.45%
ROICexc growth 5Y-15.79%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Debt/EBITDA 9.05
Cap/Depr 85.28%
Cap/Sales 7.34%
Interest Coverage 250
Cash Conversion 31.07%
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 0.98
Altman-Z 0.87
F-Score4
WACC10.03%
ROIC/WACC0.08
Cap/Depr(3y)53.43%
Cap/Depr(5y)52.81%
Cap/Sales(3y)5.03%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
EPS Next Y-10.8%
EPS Next 2Y13.94%
EPS Next 3Y20.44%
EPS Next 5Y19.96%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%
Revenue Next Year6.46%
Revenue Next 2Y6.14%
Revenue Next 3Y5.92%
Revenue Next 5Y5.49%
EBIT growth 1Y-38.95%
EBIT growth 3Y-15.55%
EBIT growth 5Y-13.93%
EBIT Next Year46.23%
EBIT Next 3Y23.51%
EBIT Next 5Y15.82%
FCF growth 1Y-880%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.07%
OCF growth 3Y-35.71%
OCF growth 5Y-21.91%

BAUSCH + LOMB CORP / BLCO FAQ

What is the fundamental rating for BLCO stock?

ChartMill assigns a fundamental rating of 3 / 10 to BLCO.


What is the valuation status of BAUSCH + LOMB CORP (BLCO) stock?

ChartMill assigns a valuation rating of 3 / 10 to BAUSCH + LOMB CORP (BLCO). This can be considered as Overvalued.


Can you provide the profitability details for BAUSCH + LOMB CORP?

BAUSCH + LOMB CORP (BLCO) has a profitability rating of 4 / 10.


What is the financial health of BAUSCH + LOMB CORP (BLCO) stock?

The financial health rating of BAUSCH + LOMB CORP (BLCO) is 1 / 10.